Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (201-210 of 357) with videos related to

Pageof 36
Sort By:
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Canadian Liver Journal|July 18, 2025
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping ReviewFelice Cinque, Clara Long, Duy A Dinh, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2019
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II StudyBrittany Knick Ragon, Olatoyosi Odenike, Maria R Baer, et al.
Plos One|December 2, 2016
Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent ChromiumXu Tian, Keyur Patel, John R Ridpath, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2008
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Paul Marotta, et al.
Cancer Genetics|September 19, 2015
Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutationMaro Ohanian, Carlos Bueso-Ramos, Chi Young Ok, et al.
NPJ Precision Oncology|March 4, 2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancerVivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 2019
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated FibrosisZita Galvin, Ramraj Rajakumar, Emily Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 31, 2018
Assessment of liver fibrosis progression and regression by a serological collagen turnover profileMorten A Karsdal, Sara T Hjuler, Yi Luo, et al.
Pageof 36

Showing results (201-210 of 357) with videos related to

Sort By:
Pageof 36
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Canadian Liver Journal|July 18, 2025
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping ReviewFelice Cinque, Clara Long, Duy A Dinh, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2019
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II StudyBrittany Knick Ragon, Olatoyosi Odenike, Maria R Baer, et al.
Plos One|December 2, 2016
Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent ChromiumXu Tian, Keyur Patel, John R Ridpath, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2008
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Paul Marotta, et al.
Cancer Genetics|September 19, 2015
Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutationMaro Ohanian, Carlos Bueso-Ramos, Chi Young Ok, et al.
NPJ Precision Oncology|March 4, 2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancerVivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 2019
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated FibrosisZita Galvin, Ramraj Rajakumar, Emily Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 31, 2018
Assessment of liver fibrosis progression and regression by a serological collagen turnover profileMorten A Karsdal, Sara T Hjuler, Yi Luo, et al.
Pageof 36